Pharmacokinetics of IgG and IgM anti-ganglioside antibodies in rats and monkeys after intrathecal administration

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 1, 1998, Pages 111-115

  Bergman, Ira ^a,e   Burckart, Gilbert J ^b   Pohl, Clifford R ^c   Venkataramanan, Raman ^b   Barmada, Mamdouha A ^a   Griffin, Judith A ^a   Cheung, Nai Kong V ^d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c DUQUESNE UNIVERSITY   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; FUROSEMIDE; GANGLIOSIDE ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CANCER; CANCER IMMUNOTHERAPY; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID FLOW; DRUG EFFICACY; DRUG ELIMINATION; INTERMETHOD COMPARISON; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEPTOMENINX; NONHUMAN; PRIORITY JOURNAL; RAT; THERAPEUTIC INDEX;

ANIMALS; ANTIBODIES, MONOCLONAL; FEMALE; GANGLIOSIDES; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INJECTIONS, INTRAVENOUS; INJECTIONS, SPINAL; MACACA MULATTA; MALE; RATS;

EID: 0031887188     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Balin BJ and Broadwell RD (1988) Transcytosis of protein through the mammalian cerebral epithelium and endothelium. I. Choroid plexus and the blood-cerebrospinal fluid barrier. Neurocytology 17:809-826.
2. 14C]inulin after intrathecal infusion. Brain Res 52:323-332.
3. Bergman I, Barmada MA, Kemp S, Griffin J and Cheung NKV (1997) A rat model of leptomeningeal human neoplastic xenografts. J Neuro-Oncol 34:221-231.
4. Betz AL, Goldstein GW and Katzman R (1989) Blood-brain-cerebrospinal fluid barriers, in Basic Neurochemistry: Molecular, Cellular, and Medical Aspects (Siegel GJ, Agranoff BW, Albers RW, Molinoff PB. eds) pp 591-606, Raven Press, New York.
5. Chamberlain MC (1994) New approaches to and current treatment of leptomeningeal metastases. Curr Opin Neurol 7:492-500.
6. Collins JM (1983) Pharmacokinetics of intraventricular administration. J NeuroOncol 1:283-291.
7. Collins JM, Grieshaber C and Chabner B (1990) Pharmacologically guided phase I clinical trials based upon preclinical drug development. J Natl Cancer Inst 82: 1321-1326.
8. Davson H and Segal MB (1996) Physiology of the CSF and Blood-Brain Barriers. CRC Press, Boca Raton.
9. DiChiro G, Knop RH, Girton ME, Dwyer AJ, Doppman JL, Patronas NK, Gansow OA, Brechbiel MW and Brooks BA (1985) MR cisternography and myelography with Gd-DTPA in monkeys. Radiology 157:373-377.
10. Harnish PP and Samuel K (1988) pharmacologic manipulation of the flushing action of cerebrospinal fluid effect on CSF diatrizoate levels. Invest Radiol 23:914-917.
11. Hertler AA, Schlossman DM, Borowitz MJ, Poplack DG and Frankel AE (1989) An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: Studies in rhesus monkeys. Cancer Immunol Immunother 28:59-66.
12. Johanson CE, Palm DE, Dyas ML and Knuckey NW (1994) Microdialysis analysis of effects of loop diuretics and acetazolamide on chloride transport from blood to CSF. Brain Res 641:121-126.
13. Larson SM, Sgouros G and Cheung NKV (1995) Radioisotope conjugates, in Biologic Therapy of Cancer (DeVita VT, Hellman S and Rosenberg SA, eds) pp 534-551, Lippincott, Philadelphia.
14. Lux WE and Fenstermacher JD (1975) Cerebrospinal fluid formation in ventricles and spinal subarachnoid space of the rhesus monkey. J Neurosurg 42:674-677.
15. McCarthy KD and Reed DJ (1974) The effect of acetazolamide and furosemide on cerebrospinal fluid production and choroid plexus carbonic anhydrase activity. J Pharmacol Exp Ther 189:194-201.
16. Muraszko K, Sung C, Walbride S, Greenfield L, Dedrick RL, Oldfield EH and Youle RJ (1993) Pharmacokinetics and toxicology of immunotoxins administered into the subarachnoid space in nonhuman primates and rodents. Cancer Res 53:3752-3757.
17. National Research Council (1956) Handbook of Biological Data. WB Saunders, Philadelphia.
18. Pardridge WM (1991) Peptide Drug Delivery to the Brain. Raven Press, New York.
19. Riccardi R, Holcenberg JS, Glaubiger DL, Wood JH and Poplack DG (1981) Asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans. Cancer Res 41:4554-4558.
20. Saunders NR (1992) Ontogenetic development of brain barrier mechanisms, in Physiology and Pharmacology of the Blood-Brain Barrier (Bradbury MWB, ed) pp 343-363, Springer-Verlag, New York.
21. Welch K and Pollay M (1961) Perfusion of particles through arachnoid villi of the monkey. Am J Physiol 201:651-654.